Berman Medical

Home

 
Michael Berman is a medical device investor/entrepreneur who serves on the boards of 11 emerging medical companies:

AngioSlide                              www.angioslide.com
Cardiosonic
ClearCut Medical  
EndoSpan                               http://www.endospan.com
InspireMD                               http://www.inspire-md.com
Mazor Robotics                      http://mazorrobotics.com/  
Owlytics                                  www.owlytics.com 
PulmOne                                http://www.pulm-one.com/ 
Rebiotix                                  http://rebiotix.com/
SoniVie
PharmaCentra                        www.PharmaCentra.com
TruLeaf Medical

RiverVest Ventures                Venture Partner/Consultant since 2014   


Mr. Berman was a co-founder of Velocimed which was sold to St. Jude Medical in April, 2005 for $82.5M.

Mr. Berman was a Director of Lutonix from 2007 until 2011 when it was sold to CR Bard for $225M, plus $100M upon FDA approval.

Mr. Berman was a co-founder and Chairman of BridgePoint Medical from 2005 till 2012 when it was sold to Boston Scientific.

Mr. Berman was a director of UltraShape inc. from 2005 till 2011 when it was sold to Syneron.

From 1995-2000 Mr. Berman was the President of the Cardiology business of Boston Scientific.

Cornell University, BS, 1979
Cornell University, MBA, 1986
Document
Michael Berman Inducted into the Minnesota Business Hall of Fame
Document
Read About Michael Berman in Twin Cities Business Monthly
Document
Read About Michael Berman in MN Business Magazine

Contact Information:

Antokolsky 3/315
Tel Aviv, 64044   Israel
Israel Mobile:       +972-52-420-3064
USA Land Line:   +1-952-512-1523
mikeb@bermanmedical.com